GCG and diabetes mellitus: An early nonrandomized pilot evaluated the safety and efficacy of a 72 h GLP-1 infusion in cardiac ICU patients (n = 21, 50 % with diabetes) with acute myocardial infarction and decreased LVEF after a successful primary angioplasty [37].